Sixty minutes opdivo, page-4

I gather Channel Ten carried a story on them a few years back. Trouble is VLA is still going through trials and although it has got some good results in its own right it works best in combination with big name drugs, pretty much second fiddle. I don't think tabloid coverage benefits a stock for very long and personally I don't feel the need for such validation. Would be a feel good thing for a short time though I admit.